Harbouring EIF2AK4 mutations confer a poor prognosis irrespective of clinical diagnosis and importantly, radiological assessments were unable to distinguish reliably between PVOD/PCH patients and patients with IPAH [111]. This evidence concerns the gene EIF2AK4 and pulmonary venoocclusive disease.